The core institutional problem is not accuracy in aggregate — it is the asymmetry of consequences. A false positive sends a patient to a clinic unnecessarily; a false negative sends a melanoma home. Dermatology practices absorbing the referral overflow from AI apps are already documenting the cost of the first failure. The second failure, less visible until it becomes a malpractice case, is what will set the enforcement and liability precedent for the entire category. The AAD's push toward augmented intelligence recast as a collaborative dermatology tool is the profession's…